These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22140253)

  • 21. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
    Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
    Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.
    Dolinska MB; Kus NJ; Farney SK; Wingfield PT; Brooks BP; Sergeev YV
    Pigment Cell Melanoma Res; 2017 Jan; 30(1):41-52. PubMed ID: 27775880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of variants in the 3'-region of the tyrosinase gene requires locus specific amplification.
    Chaki M; Mukhopadhyay A; Ray K
    Hum Mutat; 2005 Jul; 26(1):53-8. PubMed ID: 15895460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism.
    Oetting WS; Pietsch J; Brott MJ; Savage S; Fryer JP; Summers CG; King RA
    Am J Med Genet A; 2009 Mar; 149A(3):466-9. PubMed ID: 19208379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism.
    Spritz RA; Strunk KM; Hsieh CL; Sekhon GS; Francke U
    Am J Hum Genet; 1991 Feb; 48(2):318-24. PubMed ID: 1899321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional assessment of tyrosinase variants identified in individuals with albinism is essential for unequivocal determination of genotype-to-phenotype correlation.
    Mondal M; Sengupta M; Ray K
    Br J Dermatol; 2016 Dec; 175(6):1232-1242. PubMed ID: 27537549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of 53 novel DNA variations within the tyrosinase gene and accumulation of mutations in 17 patients with albinism.
    Opitz S; Käsmann-Kellner B; Kaufmann M; Schwinger E; Zühlke C
    Hum Mutat; 2004 Jun; 23(6):630-1. PubMed ID: 15146472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type I oculocutaneous albinism associated with a full-length deletion of the tyrosinase gene.
    Schnur RE; Sellinger BT; Holmes SA; Wick PA; Tatsumura YO; Spritz RA
    J Invest Dermatol; 1996 May; 106(5):1137-40. PubMed ID: 8618053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insertion/deletion mutations of type I oculocutaneous albinism in chinese patients from Taiwan.
    Tsai CH; Tsai FJ; Wu JY; Lin SP; Chang JG; Yang CF; Lee CC
    Hum Mutat; 1999 Dec; 14(6):542. PubMed ID: 10571953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel and recurrent mutations in the tyrosinase gene and the P gene in the German albino population.
    Passmore LA; Kaesmann-Kellner B; Weber BH
    Hum Genet; 1999 Sep; 105(3):200-10. PubMed ID: 10987646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis of oculocutaneous albinism type 1 in Lebanese patients.
    Zahed L; Zahreddine H; Noureddine B; Rebeiz N; Shakar N; Zalloua P; Haddad F
    J Hum Genet; 2005; 50(6):317-319. PubMed ID: 15937636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analyses of a tyrosinase-negative albino family.
    Park KC; Chintamaneni CD; Halaban R; Witkop CJ; Kwon BS
    Am J Hum Genet; 1993 Feb; 52(2):406-13. PubMed ID: 8430701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. R278TER and P431L mutations of the tyrosinase gene exist in Japanese patients with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J; Dakeishi M; Shimizu H; Tomita Y
    J Dermatol Sci; 1996 Nov; 13(2):134-9. PubMed ID: 8953413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1.
    Ray K; Chaki M; Sengupta M
    Prog Retin Eye Res; 2007 Jul; 26(4):323-58. PubMed ID: 17355913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New nonsense mutation (p.E250X) in the tyrosinase gene of a patient with oculocutaneous albinism type 1A].
    Aquaron R; Hesse S; Badens C; Bonerandi JJ
    Ann Dermatol Venereol; 2009 Jan; 136(1):57-9. PubMed ID: 19171234
    [No Abstract]   [Full Text] [Related]  

  • 36. Oculocutaneous albinism in the i6 mutant of the medaka fish is associated with a deletion in the tyrosinase gene.
    Koga A; Wakamatsu Y; Kurosawa J; Hori H
    Pigment Cell Res; 1999 Aug; 12(4):252-8. PubMed ID: 10454293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Tyrosinase missense mutation causes albinism in the Wistar rat.
    Blaszczyk WM; Arning L; Hoffmann KP; Epplen JT
    Pigment Cell Res; 2005 Apr; 18(2):144-5. PubMed ID: 15760344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1).
    Spritz RA; Oh J; Fukai K; Holmes SA; Ho L; Chitayat D; France TD; Musarella MA; Orlow SJ; Schnur RE; Weleber RG; Levin AV
    Hum Mutat; 1997; 10(2):171-4. PubMed ID: 9259202
    [No Abstract]   [Full Text] [Related]  

  • 39. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism.
    Matsunaga J; Takeda A; Tomita Y; Hara M; Shibahara S; Tagami H
    J Dermatol Sci; 1992 May; 3(3):181-5. PubMed ID: 1498098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations of the tyrosinase gene in oculocutaneous albinism.
    Shibahara S
    Pigment Cell Res; 1992 Nov; 5(5 Pt 2):279-83. PubMed ID: 1292010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.